Menu
GeneBe

HSD17B12

hydroxysteroid 17-beta dehydrogenase 12, the group of Short chain dehydrogenase/reductase superfamily

Basic information

Region (hg38): 11:43680679-43856617

Links

ENSG00000149084NCBI:51144OMIM:609574HGNC:18646Uniprot:Q53GQ0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the HSD17B12 gene.

  • Inborn genetic diseases (11 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the HSD17B12 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
10
clinvar
1
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 10 1 0

Variants in HSD17B12

This is a list of pathogenic ClinVar variants found in the HSD17B12 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-43680844-C-T not specified Uncertain significance (Mar 08, 2024)3107099
11-43680940-G-A not specified Uncertain significance (Jan 17, 2024)3107098
11-43680967-C-T not specified Uncertain significance (Aug 08, 2022)2367111
11-43750955-G-A not specified Uncertain significance (Oct 06, 2022)2317634
11-43754106-G-T not specified Uncertain significance (Oct 30, 2023)3107100
11-43754120-A-G not specified Uncertain significance (May 24, 2023)2551743
11-43798363-T-G not specified Uncertain significance (Sep 17, 2021)2354122
11-43798364-G-T not specified Uncertain significance (Jul 21, 2021)2239089
11-43798398-G-A not specified Uncertain significance (Jan 03, 2024)3107101
11-43798404-C-T not specified Uncertain significance (Feb 15, 2023)2464531
11-43798422-T-C not specified Uncertain significance (Jun 14, 2023)2560289
11-43815500-A-G not specified Uncertain significance (Jan 31, 2024)3107102
11-43838364-C-G not specified Uncertain significance (Feb 15, 2024)3107103
11-43840021-A-T not specified Uncertain significance (Jun 13, 2022)2371768
11-43840053-G-A not specified Likely benign (Jun 02, 2023)2510235
11-43854785-C-T not specified Uncertain significance (Oct 03, 2023)3107104
11-43854791-C-T not specified Uncertain significance (Aug 28, 2023)2590779
11-43855154-T-A not specified Uncertain significance (Apr 25, 2022)2286063
11-43855202-A-C not specified Uncertain significance (Oct 26, 2021)3107105
11-43855241-A-T not specified Uncertain significance (Dec 28, 2023)3107106

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
HSD17B12protein_codingprotein_codingENST00000278353 11300182
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0004030.9631257230251257480.0000994
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6491471710.8600.000008492010
Missense in Polyphen4050.580.79083615
Synonymous-0.4327469.41.070.00000378615
Loss of Function1.86816.00.4996.74e-7214

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002750.000275
Ashkenazi Jewish0.0001000.0000992
East Asian0.0001110.000109
Finnish0.000.00
European (Non-Finnish)0.0001340.000132
Middle Eastern0.0001110.000109
South Asian0.00006660.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the second of the four reactions of the long- chain fatty acids elongation cycle. This endoplasmic reticulum- bound enzymatic process, allows the addition of two carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. This enzyme has a 3-ketoacyl-CoA reductase activity, reducing 3- ketoacyl-CoA to 3-hydroxyacyl-CoA, within each cycle of fatty acid elongation. Thereby, it may participate in the production of VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May also catalyze the transformation of estrone (E1) into estradiol (E2) and play a role in estrogen formation. {ECO:0000269|PubMed:12482854, ECO:0000269|PubMed:16166196}.;
Pathway
Steroid hormone biosynthesis - Homo sapiens (human);Biosynthesis of unsaturated fatty acids - Homo sapiens (human);Fatty acid elongation - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Metabolism of lipids;Fatty acyl-CoA biosynthesis;Glycine Serine metabolism;Androgen and estrogen biosynthesis and metabolism;Metabolism;Fatty acid metabolism;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of steroids;C21-steroid hormone biosynthesis and metabolism;Synthesis of very long-chain fatty acyl-CoAs;Steroid hormones (Consensus)

Recessive Scores

pRec
0.198

Intolerance Scores

loftool
0.509
rvis_EVS
0.06
rvis_percentile_EVS
58.53

Haploinsufficiency Scores

pHI
0.111
hipred
N
hipred_score
0.341
ghis
0.458

Essentials

essential_gene_CRISPR
E
essential_gene_CRISPR2
S
essential_gene_gene_trap
E
gene_indispensability_pred
E
gene_indispensability_score
0.945

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Hsd17b12
Phenotype
cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; cellular phenotype; growth/size/body region phenotype;

Gene ontology

Biological process
fatty acid biosynthetic process;estrogen biosynthetic process;positive regulation of cell-substrate adhesion;extracellular matrix organization;long-chain fatty-acyl-CoA biosynthetic process;oxidation-reduction process
Cellular component
endoplasmic reticulum membrane;integral component of membrane;extracellular matrix
Molecular function
fibronectin binding;estradiol 17-beta-dehydrogenase activity;protein binding;collagen binding;heparin binding;long-chain-3-hydroxyacyl-CoA dehydrogenase activity;3-oxo-arachidoyl-CoA reductase activity;3-oxo-behenoyl-CoA reductase activity;3-oxo-lignoceroyl-CoA reductase activity;3-oxo-cerotoyl-CoA reductase activity